Gilead Sciences Inc. said Monday its four-in-one HIV treatment met key goals in a midstage study.
View full post on All News, Video and Posts related to SECTOR: Health Care
Popular Posts:
- AMCP Review of Health Care Reform Legislation (Part 1)
- Anadys hepatitis C drug meets key study goals
- Summary Box: Lilly halts Alzheimer’s drug
- Medicare Prescription Drug Coverage For Dummies
- Bristol-Myers reports diabetes drug results